VRPX

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) is a preclinical-stage pharmaceutical company founded in 2016 and headquartered in Berwyn, Pennsylvania. The company went public in February 2021 and focuses on developing innovative drug-delivery systems and drug-releasing technologies for non-opioid pain management and central nervous system disorders. Since its founding, Virpax has been working to address the ongoing opioid crisis by creating alternative pain management solutions that avoid the addictive properties of traditional opioid medications.